These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19365853)

  • 1. Prognostic significance of carbonic anhydrase IX expression by cancer-associated fibroblasts in lung adenocarcinoma.
    Nakao M; Ishii G; Nagai K; Kawase A; Kenmotsu H; Kon-No H; Hishida T; Nishimura M; Yoshida J; Ochiai A
    Cancer; 2009 Jun; 115(12):2732-43. PubMed ID: 19365853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
    Colpaert CG; Vermeulen PB; Fox SB; Harris AL; Dirix LY; Van Marck EA
    Breast Cancer Res Treat; 2003 Sep; 81(2):137-47. PubMed ID: 14572156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
    Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
    Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.
    Yan P; Li YH; Tang ZJ; Shu X; Liu X
    Asian Pac J Cancer Prev; 2014; 15(20):8923-9. PubMed ID: 25374230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
    Le QT; Chen E; Salim A; Cao H; Kong CS; Whyte R; Donington J; Cannon W; Wakelee H; Tibshirani R; Mitchell JD; Richardson D; O'Byrne KJ; Koong AC; Giaccia AJ
    Clin Cancer Res; 2006 Mar; 12(5):1507-14. PubMed ID: 16533775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
    J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.
    Haapasalo JA; Nordfors KM; Hilvo M; Rantala IJ; Soini Y; Parkkila AK; Pastoreková S; Pastorek J; Parkkila SM; Haapasalo HK
    Clin Cancer Res; 2006 Jan; 12(2):473-7. PubMed ID: 16428489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma.
    Chia SK; Wykoff CC; Watson PH; Han C; Leek RD; Pastorek J; Gatter KC; Ratcliffe P; Harris AL
    J Clin Oncol; 2001 Aug; 19(16):3660-8. PubMed ID: 11504747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase IX in early-stage non-small cell lung cancer.
    Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ
    Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hypoxic marker carbonic anhydrase IX predicts poor prognosis in resectable hepatocellular carcinoma.
    Huang WJ; Jeng YM; Lai HS; Fong IU; Sheu FY; Lai PL; Yuan RH
    PLoS One; 2015; 10(3):e0119181. PubMed ID: 25738958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma.
    Kon-no H; Ishii G; Nagai K; Yoshida J; Nishimura M; Nara M; Fujii T; Murata Y; Miyamoto H; Ochiai A
    Lung Cancer; 2006 Dec; 54(3):409-18. PubMed ID: 17030461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A; Landuyt W; Pastorekova S; Moons J; Goethals L; Haustermans K; Nafteux P; Penninckx F; Geboes K; Lerut T; Ectors N
    Ann Surg; 2006 Mar; 243(3):334-40. PubMed ID: 16495697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer.
    Simi L; Venturini G; Malentacchi F; Gelmini S; Andreani M; Janni A; Pastorekova S; Supuran CT; Pazzagli M; Orlando C
    Lung Cancer; 2006 Apr; 52(1):59-66. PubMed ID: 16513206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome.
    Trastour C; Benizri E; Ettore F; Ramaioli A; Chamorey E; Pouysségur J; Berra E
    Int J Cancer; 2007 Apr; 120(7):1451-8. PubMed ID: 17245699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
    Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.
    Beketic-Oreskovic L; Ozretic P; Rabbani ZN; Jackson IL; Sarcevic B; Levanat S; Maric P; Babic I; Vujaskovic Z
    Pathol Oncol Res; 2011 Sep; 17(3):593-603. PubMed ID: 21249485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype.
    Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A
    Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
    Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
    Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer.
    Mees G; Vangestel C; Dierckx R; Pauwels P; Van Meerbeeck J; Van de Wiele C
    Cancer Biother Radiopharm; 2010 Apr; 25(2):149-54. PubMed ID: 20423227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of carbonic anhydrase IX in craniopharyngiomas.
    Proescholdt M; Merrill M; Stoerr EM; Lohmeier A; Dietmaier W; Brawanski A
    J Neurosurg; 2011 Oct; 115(4):796-801. PubMed ID: 21761968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.